Skill Tracer
Skills › Scientific Agent Skills › research-grants › specific_aims_guide.md

specific_aims_guide.md

464 lines · skills/research-grants/references/specific_aims_guide.md at 5f2bc03

Open on GitHub
1# NIH Specific Aims Page: The Complete Guide
2
3Reviewed 2026-10-01. This is writing advice, not an official template. All sample
4research, preliminary results, statistics, sample sizes and resources below are
5hypothetical, unvalidated teaching examples. Replace them with investigator-provided
6evidence and current primary citations; do not submit them as real findings. Follow
7[NIH application policy](https://grants.nih.gov/grants/policy/nihgps/HTML5/section_2/2.3.7_policies_affecting_applications.htm)
8on limited AI assistance and applicant ownership. Read `nih_guidelines.md` for current
9review/form requirements before using these patterns.

NIH Specific Aims Page: The Complete Guide

Reviewed 2026-10-01. This is writing advice, not an official template. All sample research, preliminary results, statistics, sample sizes and resources below are hypothetical, unvalidated teaching examples. Replace them with investigator-provided evidence and current primary citations; do not submit them as real findings. Follow NIH application policy on limited AI assistance and applicant ownership. Read nih_guidelines.md for current review/form requirements before using these patterns.

Raw lines 1 to 10
11## Overview
13The **Specific Aims page** gives reviewers a compact map of the question, planned work and contribution. Make it understandable on its own while ensuring the full research strategy supports every claim.
15**Length**: Up to 1 page for standard applications; verify the NOFO
16**Margins**: At least 0.5 inches (all sides)
17**Font**: At least 11-point body text; graphic text follows the attachment-rule exception
18**Line spacing**: At most six lines per vertical inch; at most 15 characters per horizontal inch. See [NIH attachment rules](https://www.grants.nih.gov/grants-process/write-application/how-to-apply-application-guide/format-attachments).
20**Purpose**:
21- Communicate your research vision clearly and compellingly
22- Establish significance and innovation
23- Demonstrate feasibility
24- Show that you can accomplish meaningful work in the proposed timeframe
25- Make reviewers excited to fund your work

Overview

The Specific Aims page gives reviewers a compact map of the question, planned work and contribution. Make it understandable on its own while ensuring the full research strategy supports every claim.

Length: Up to 1 page for standard applications; verify the NOFO Margins: At least 0.5 inches (all sides) Font: At least 11-point body text; graphic text follows the attachment-rule exception Line spacing: At most six lines per vertical inch; at most 15 characters per horizontal inch. See NIH attachment rules.

Purpose:

  • Communicate your research vision clearly and compellingly
  • Establish significance and innovation
  • Demonstrate feasibility
  • Show that you can accomplish meaningful work in the proposed timeframe
  • Make reviewers excited to fund your work
Raw lines 11 to 26
27## Anatomy of a Specific Aims Page

Anatomy of a Specific Aims Page

Raw lines 27 to 28
29### Suggested drafting sequence (not a mandated format)
311. **Opening Hook** (2-4 sentences)
322. **Gap/Problem Statement** (2-4 sentences)
333. **Long-Term Goal** (1 sentence)
344. **Objective** (1-2 sentences)
355. **Central Hypothesis** (1 sentence) [or Research Questions]
366. **Rationale** (2-3 sentences with preliminary data mention)
377. **Specific Aims** (enough to answer the question within the project's scope)
388. **Expected Outcomes and Impact** (2-4 sentences)

Suggested drafting sequence (not a mandated format)

  1. Opening Hook (2-4 sentences)
  2. Gap/Problem Statement (2-4 sentences)
  3. Long-Term Goal (1 sentence)
  4. Objective (1-2 sentences)
  5. Central Hypothesis (1 sentence) [or Research Questions]
  6. Rationale (2-3 sentences with preliminary data mention)
  7. Specific Aims (enough to answer the question within the project's scope)
  8. Expected Outcomes and Impact (2-4 sentences)
Raw lines 29 to 39
40## Detailed Structure

Detailed Structure

Raw lines 40 to 41
42### Opening Paragraph: The Hook
44**Purpose**: Establish importance and grab attention
46**What to include**:
47- Broad context (disease burden, biological importance, technological need)
48- Epidemiological data or statistics that establish scale
49- Why this problem matters for health or science
50- Create urgency
52**Length**: 2-4 sentences
54**Writing tips**:
55- Start strong with compelling statement
56- Use concrete numbers (prevalence, mortality, costs)
57- Avoid jargon in first sentence
58- Make it accessible to non-specialists on panel
60**Examples**:
62*Clinical Example*:
63"Pancreatic cancer causes [current, cited burden]. Existing [specified diagnostic or therapeutic approaches] leave [evidence-supported limitation]. Resolving [defined gap] could enable [bounded scientific contribution]."
65*Basic Science Example*:
66"Mitochondrial dysfunction is a hallmark of aging and age-related diseases, yet the mechanisms linking mitochondrial decline to cellular senescence remain poorly understood. Emerging evidence suggests that mitochondrial-nuclear communication pathways play a central role in longevity determination across species, from yeast to mammals. Understanding how cells sense and respond to mitochondrial stress could reveal new therapeutic targets for age-related diseases affecting millions worldwide."

Opening Paragraph: The Hook

Purpose: Establish importance and grab attention

What to include:

  • Broad context (disease burden, biological importance, technological need)
  • Epidemiological data or statistics that establish scale
  • Why this problem matters for health or science
  • Create urgency

Length: 2-4 sentences

Writing tips:

  • Start strong with compelling statement
  • Use concrete numbers (prevalence, mortality, costs)
  • Avoid jargon in first sentence
  • Make it accessible to non-specialists on panel

Examples:

Clinical Example: "Pancreatic cancer causes [current, cited burden]. Existing [specified diagnostic or therapeutic approaches] leave [evidence-supported limitation]. Resolving [defined gap] could enable [bounded scientific contribution]."

Basic Science Example: "Mitochondrial dysfunction is a hallmark of aging and age-related diseases, yet the mechanisms linking mitochondrial decline to cellular senescence remain poorly understood. Emerging evidence suggests that mitochondrial-nuclear communication pathways play a central role in longevity determination across species, from yeast to mammals. Understanding how cells sense and respond to mitochondrial stress could reveal new therapeutic targets for age-related diseases affecting millions worldwide."

Raw lines 42 to 67
68### Second Paragraph: Gap and Context
70**Purpose**: Define what's known, what's unknown, and why it matters
72**What to include**:
73- Current state of knowledge (brief literature context)
74- Specific gap or barrier to progress
75- Why this gap is critical to address
76- Why current approaches are insufficient
78**Length**: 3-5 sentences
80**Structure**:
811. What we know (1-2 sentences)
822. What we don't know / what's limiting progress (1-2 sentences)
833. Why this gap matters (1 sentence)
85**Examples**:
87"Prior studies have identified numerous genetic mutations associated with PDAC development, including KRAS, TP53, SMAD4, and CDKN2A. However, the tumor microenvironment (TME), comprising immune cells, fibroblasts, and extracellular matrix, is increasingly recognized as a critical determinant of therapeutic resistance. Current models fail to recapitulate the complex TME architecture and cell-cell interactions that drive therapy resistance in vivo, limiting our ability to develop effective treatments. Understanding how the TME protects tumor cells from chemotherapy is essential for designing combination therapies that overcome resistance."

Second Paragraph: Gap and Context

Purpose: Define what's known, what's unknown, and why it matters

What to include:

  • Current state of knowledge (brief literature context)
  • Specific gap or barrier to progress
  • Why this gap is critical to address
  • Why current approaches are insufficient

Length: 3-5 sentences

Structure:

  1. What we know (1-2 sentences)
  2. What we don't know / what's limiting progress (1-2 sentences)
  3. Why this gap matters (1 sentence)

Examples:

"Prior studies have identified numerous genetic mutations associated with PDAC development, including KRAS, TP53, SMAD4, and CDKN2A. However, the tumor microenvironment (TME), comprising immune cells, fibroblasts, and extracellular matrix, is increasingly recognized as a critical determinant of therapeutic resistance. Current models fail to recapitulate the complex TME architecture and cell-cell interactions that drive therapy resistance in vivo, limiting our ability to develop effective treatments. Understanding how the TME protects tumor cells from chemotherapy is essential for designing combination therapies that overcome resistance."

Raw lines 68 to 88
89### Third Paragraph: Long-Term Goal, Objective, Hypothesis, Rationale
91**Purpose**: Set up your specific approach and justification
93**Structure**:
95**Long-Term Goal** (1 sentence):
96- Your overarching research program direction
97- Broader than this specific proposal
98- Provides context for this work
100*Example*: "The long-term goal of our research is to elucidate the molecular mechanisms by which the tumor microenvironment promotes therapeutic resistance in pancreatic cancer."
102**Objective** (1-2 sentences):
103- Specific objective of THIS grant
104- What you will accomplish during the permitted project period
105- More focused than long-term goal
107*Example*: "The objective of this application is to define the role of cancer-associated fibroblasts (CAFs) in mediating gemcitabine resistance and to develop combination therapies targeting CAF-tumor interactions."
109**Central Hypothesis** (1 sentence):
110- Testable prediction
111- Should unify the specific aims
112- Based on preliminary data or logical reasoning
113- Clear and specific
115*Example*: "Our central hypothesis is that CAF-secreted factors activate protective autophagy in tumor cells, conferring resistance to gemcitabine, and that dual inhibition of CAF signaling and autophagy will restore drug sensitivity."
117**Alternative: Research Questions** (if hypothesis-testing isn't appropriate):
118- 2-3 focused questions
119- Should correspond to specific aims
121*Example*: "This project will address the following questions: (1) What factors secreted by CAFs promote tumor cell survival during chemotherapy? (2) How do tumor cells integrate CAF signals to activate protective responses? (3) Can targeting CAF-tumor interactions enhance therapeutic efficacy in preclinical models?"
123**Rationale** (2-3 sentences):
124- Why you think the hypothesis is true
125- Mention key preliminary data (very briefly)
126- Logical basis for your approach
127- Why this approach will work
129*Example*: "This hypothesis is based on our preliminary data showing that CAF-conditioned medium protects tumor cells from gemcitabine-induced apoptosis by 60% (Fig. 1), and that this protection is blocked by autophagy inhibitors (Fig. 2). Proteomic analysis of CAF secretomes identified 15 candidate factors enriched in drug-resistant contexts (Table 1). These findings suggest a targetable pathway linking CAF signaling to tumor cell survival that could be exploited therapeutically."

Third Paragraph: Long-Term Goal, Objective, Hypothesis, Rationale

Purpose: Set up your specific approach and justification

Structure:

Long-Term Goal (1 sentence):

  • Your overarching research program direction
  • Broader than this specific proposal
  • Provides context for this work

Example: "The long-term goal of our research is to elucidate the molecular mechanisms by which the tumor microenvironment promotes therapeutic resistance in pancreatic cancer."

Objective (1-2 sentences):

  • Specific objective of THIS grant
  • What you will accomplish during the permitted project period
  • More focused than long-term goal

Example: "The objective of this application is to define the role of cancer-associated fibroblasts (CAFs) in mediating gemcitabine resistance and to develop combination therapies targeting CAF-tumor interactions."

Central Hypothesis (1 sentence):

  • Testable prediction
  • Should unify the specific aims
  • Based on preliminary data or logical reasoning
  • Clear and specific

Example: "Our central hypothesis is that CAF-secreted factors activate protective autophagy in tumor cells, conferring resistance to gemcitabine, and that dual inhibition of CAF signaling and autophagy will restore drug sensitivity."

Alternative: Research Questions (if hypothesis-testing isn't appropriate):

  • 2-3 focused questions
  • Should correspond to specific aims

Example: "This project will address the following questions: (1) What factors secreted by CAFs promote tumor cell survival during chemotherapy? (2) How do tumor cells integrate CAF signals to activate protective responses? (3) Can targeting CAF-tumor interactions enhance therapeutic efficacy in preclinical models?"

Rationale (2-3 sentences):

  • Why you think the hypothesis is true
  • Mention key preliminary data (very briefly)
  • Logical basis for your approach
  • Why this approach will work

Example: "This hypothesis is based on our preliminary data showing that CAF-conditioned medium protects tumor cells from gemcitabine-induced apoptosis by 60% (Fig. 1), and that this protection is blocked by autophagy inhibitors (Fig. 2). Proteomic analysis of CAF secretomes identified 15 candidate factors enriched in drug-resistant contexts (Table 1). These findings suggest a targetable pathway linking CAF signaling to tumor cell survival that could be exploited therapeutically."

Raw lines 89 to 130
131### Specific Aims (Main Section)
133**How many aims**: Choose the number supported by the question, scope and resources.
134Two or three is a common drafting pattern, not an NIH requirement. One coherent aim
135can be appropriate; many large aims can exceed feasible scope.
137**Structure for each aim**:
1381. **Aim Statement** (1-2 sentences, bold or underlined)
1392. **Rationale and Background** (1-3 sentences)
1403. **Working Hypothesis** (1 sentence, if applicable)
1414. **Approach Summary** (2-4 sentences)
1425. **Expected Outcomes and Interpretation** (1-2 sentences)
144**Length per aim**: Keep the combined narrative within the actual page maximum; the expanded teaching examples below are not a one-page finished layout.
146**Relationships between aims**:
147- **Independent**: Failure of one aim doesn't doom the others
148- **Synergistic**: Aims build on each other or address complementary questions
149- **Progressive**: Aim 1 enables Aim 2, Aim 2 enables Aim 3 (be careful—creates risk)
151#### Example Aim Structure:
153**Aim 1: Identify CAF-secreted factors that mediate gemcitabine resistance.**
155*Rationale*: CAF-conditioned medium confers significant protection against gemcitabine (Fig. 1), suggesting secreted factors are responsible. We have identified 15 candidate proteins enriched in CAF secretomes from resistant versus sensitive contexts (Table 1).
157*Working Hypothesis*: CAFs secrete specific growth factors and cytokines (including IL-6, CXCL12, and HGF) that activate pro-survival pathways in tumor cells.
159*Approach*: We will (1) validate candidate factors using neutralizing antibodies in co-culture assays, (2) measure activation of downstream signaling pathways (STAT3, PI3K/AKT, MAPK) in tumor cells, and (3) perform CRISPR screens in CAFs to identify factors required for resistance phenotype. We will use patient-derived CAFs and tumor cells to ensure clinical relevance.
161*Expected Outcomes*: We expect to identify 3-5 CAF-secreted factors sufficient and necessary for gemcitabine resistance, and define their signaling mechanisms. These will serve as therapeutic targets for Aims 2-3.
163---
165**Aim 2: Determine the mechanisms by which CAF signals activate protective autophagy in tumor cells.**
167*Rationale*: Our data show that CAF-mediated resistance requires autophagy (Fig. 2), but the signaling pathways linking CAF factors to autophagy activation remain unknown.
169*Working Hypothesis*: CAF-secreted factors activate mTOR-independent autophagy through AMPK and ULK1 phosphorylation.
171*Approach*: We will (1) measure autophagy flux in tumor cells exposed to CAF factors using LC3 turnover assays and electron microscopy, (2) define signaling pathways using phosphoproteomic analysis and pharmacologic inhibitors, and (3) validate pathways using genetic knockdowns (shRNA/CRISPR) of key nodes. Studies will be performed in 2D and 3D co-culture systems.
173*Expected Outcomes*: We will define the signaling cascade from CAF factors to autophagy activation, identifying druggable nodes for combination therapy. Results will inform Aim 3 therapeutic strategies.
175---
177**Aim 3: Evaluate combination therapies targeting CAF-tumor interactions in preclinical models.**
179*Rationale*: Single-agent therapies targeting CAFs or autophagy have shown limited efficacy clinically, suggesting combination approaches are needed.
181*Working Hypothesis*: Dual inhibition of CAF signaling and autophagy will synergistically restore gemcitabine sensitivity in vivo.
183*Approach*: Using patient-derived xenograft (PDX) models and genetically engineered mouse models (GEMM) of PDAC, we will test combinations of (1) gemcitabine + CAF pathway inhibitors identified in Aim 1, (2) gemcitabine + autophagy inhibitors, and (3) triple combinations. We will assess tumor growth, survival, and mechanism (IHC, RNA-seq) in n=10-15 mice per group.
185*Expected Outcomes*: We expect combination therapies will reduce tumor growth by ≥60% compared to gemcitabine alone, with synergistic effects. The most effective regimen will be advanced toward clinical translation through an investigator-initiated trial (we have IND-enabling resources available at our institution).

Specific Aims (Main Section)

How many aims: Choose the number supported by the question, scope and resources. Two or three is a common drafting pattern, not an NIH requirement. One coherent aim can be appropriate; many large aims can exceed feasible scope.

Structure for each aim:

  1. Aim Statement (1-2 sentences, bold or underlined)
  2. Rationale and Background (1-3 sentences)
  3. Working Hypothesis (1 sentence, if applicable)
  4. Approach Summary (2-4 sentences)
  5. Expected Outcomes and Interpretation (1-2 sentences)

Length per aim: Keep the combined narrative within the actual page maximum; the expanded teaching examples below are not a one-page finished layout.

Relationships between aims:

  • Independent: Failure of one aim doesn't doom the others
  • Synergistic: Aims build on each other or address complementary questions
  • Progressive: Aim 1 enables Aim 2, Aim 2 enables Aim 3 (be careful—creates risk)

Example Aim Structure:

Aim 1: Identify CAF-secreted factors that mediate gemcitabine resistance.

Rationale: CAF-conditioned medium confers significant protection against gemcitabine (Fig. 1), suggesting secreted factors are responsible. We have identified 15 candidate proteins enriched in CAF secretomes from resistant versus sensitive contexts (Table 1).

Working Hypothesis: CAFs secrete specific growth factors and cytokines (including IL-6, CXCL12, and HGF) that activate pro-survival pathways in tumor cells.

Approach: We will (1) validate candidate factors using neutralizing antibodies in co-culture assays, (2) measure activation of downstream signaling pathways (STAT3, PI3K/AKT, MAPK) in tumor cells, and (3) perform CRISPR screens in CAFs to identify factors required for resistance phenotype. We will use patient-derived CAFs and tumor cells to ensure clinical relevance.

Expected Outcomes: We expect to identify 3-5 CAF-secreted factors sufficient and necessary for gemcitabine resistance, and define their signaling mechanisms. These will serve as therapeutic targets for Aims 2-3.


Aim 2: Determine the mechanisms by which CAF signals activate protective autophagy in tumor cells.

Rationale: Our data show that CAF-mediated resistance requires autophagy (Fig. 2), but the signaling pathways linking CAF factors to autophagy activation remain unknown.

Working Hypothesis: CAF-secreted factors activate mTOR-independent autophagy through AMPK and ULK1 phosphorylation.

Approach: We will (1) measure autophagy flux in tumor cells exposed to CAF factors using LC3 turnover assays and electron microscopy, (2) define signaling pathways using phosphoproteomic analysis and pharmacologic inhibitors, and (3) validate pathways using genetic knockdowns (shRNA/CRISPR) of key nodes. Studies will be performed in 2D and 3D co-culture systems.

Expected Outcomes: We will define the signaling cascade from CAF factors to autophagy activation, identifying druggable nodes for combination therapy. Results will inform Aim 3 therapeutic strategies.


Aim 3: Evaluate combination therapies targeting CAF-tumor interactions in preclinical models.

Rationale: Single-agent therapies targeting CAFs or autophagy have shown limited efficacy clinically, suggesting combination approaches are needed.

Working Hypothesis: Dual inhibition of CAF signaling and autophagy will synergistically restore gemcitabine sensitivity in vivo.

Approach: Using patient-derived xenograft (PDX) models and genetically engineered mouse models (GEMM) of PDAC, we will test combinations of (1) gemcitabine + CAF pathway inhibitors identified in Aim 1, (2) gemcitabine + autophagy inhibitors, and (3) triple combinations. We will assess tumor growth, survival, and mechanism (IHC, RNA-seq) in n=10-15 mice per group.

Expected Outcomes: We expect combination therapies will reduce tumor growth by ≥60% compared to gemcitabine alone, with synergistic effects. The most effective regimen will be advanced toward clinical translation through an investigator-initiated trial (we have IND-enabling resources available at our institution).

Raw lines 131 to 186
187### Closing Paragraph: Impact and Significance
189**Purpose**: Leave reviewers with enthusiasm and clear understanding of importance
191**What to include**:
192- Expected outcomes of the overall project
193- How findings will advance the field
194- Positive impact on health or science
195- Next steps or future directions
196- Why this matters
198**Length**: 2-4 sentences
200**Writing tips**:
201- Be confident but not arrogant
202- Connect back to opening (full circle)
203- Emphasize transformative potential
204- Avoid over-promising
206**Examples**:
208"The proposed research is significant because it will define a novel mechanism of chemotherapy resistance in pancreatic cancer and identify new therapeutic targets to overcome this resistance. Results will provide mechanistic insights into CAF-tumor interactions that drive drug resistance, immediately applicable to clinical trial design. We expect findings will enable rational design of combination therapies that improve outcomes for PDAC patients, who currently have few effective treatment options. This work will establish new paradigms for targeting the tumor microenvironment in solid cancers."

Closing Paragraph: Impact and Significance

Purpose: Leave reviewers with enthusiasm and clear understanding of importance

What to include:

  • Expected outcomes of the overall project
  • How findings will advance the field
  • Positive impact on health or science
  • Next steps or future directions
  • Why this matters

Length: 2-4 sentences

Writing tips:

  • Be confident but not arrogant
  • Connect back to opening (full circle)
  • Emphasize transformative potential
  • Avoid over-promising

Examples:

"The proposed research is significant because it will define a novel mechanism of chemotherapy resistance in pancreatic cancer and identify new therapeutic targets to overcome this resistance. Results will provide mechanistic insights into CAF-tumor interactions that drive drug resistance, immediately applicable to clinical trial design. We expect findings will enable rational design of combination therapies that improve outcomes for PDAC patients, who currently have few effective treatment options. This work will establish new paradigms for targeting the tumor microenvironment in solid cancers."

Raw lines 187 to 209
210## Writing Principles

Writing Principles

Raw lines 210 to 211
212### Clarity and Accessibility
214**Write for a mixed audience**:
215- Some panel members will be experts in your area
216- Others will be in related but not identical fields
217- Program officers and council members will read it
218- Reviewers should be able to understand the overall logic from this page
220**Strategies**:
221- Define technical terms at first use
222- Explain abbreviations (except very common ones)
223- Use clear, direct language
224- Avoid excessive jargon
225- Make logical flow obvious

Clarity and Accessibility

Write for a mixed audience:

  • Some panel members will be experts in your area
  • Others will be in related but not identical fields
  • Program officers and council members will read it
  • Reviewers should be able to understand the overall logic from this page

Strategies:

  • Define technical terms at first use
  • Explain abbreviations (except very common ones)
  • Use clear, direct language
  • Avoid excessive jargon
  • Make logical flow obvious
Raw lines 212 to 226
227### Confidence Without Arrogance
229**Confident** ✅:
230- "Our preliminary data demonstrate..."
231- "We have established a robust model system..."
232- "This approach will elucidate..."
234**Arrogant** ❌:
235- "We are uniquely qualified..."
236- "Only our lab can do this..."
237- "This will revolutionize the field..."
239**Tentative** ❌:
240- "We hope to..."
241- "We will try to..."
242- "It is possible that..."

Confidence Without Arrogance

Confident ✅:

  • "Our preliminary data demonstrate..."
  • "We have established a robust model system..."
  • "This approach will elucidate..."

Arrogant ❌:

  • "We are uniquely qualified..."
  • "Only our lab can do this..."
  • "This will revolutionize the field..."

Tentative ❌:

  • "We hope to..."
  • "We will try to..."
  • "It is possible that..."
Raw lines 227 to 243
244### Active and Specific
246**Aim statements should**:
247- Start with action verbs (Determine, Identify, Elucidate, Define, Characterize, Validate, Develop)
248- Be specific and testable
249- Indicate what will be learned
251**Weak Aim** ❌:
252"Aim 1: Study the role of protein X in disease Y"
254**Strong Aim** ✅:
255"Aim 1: Determine how protein X phosphorylation regulates disease Y progression using genetic and pharmacologic approaches"

Active and Specific

Aim statements should:

  • Start with action verbs (Determine, Identify, Elucidate, Define, Characterize, Validate, Develop)
  • Be specific and testable
  • Indicate what will be learned

Weak Aim ❌: "Aim 1: Study the role of protein X in disease Y"

Strong Aim ✅: "Aim 1: Determine how protein X phosphorylation regulates disease Y progression using genetic and pharmacologic approaches"

Raw lines 244 to 256
257### Show Feasibility
259**Throughout the aims page**:
260- Mention preliminary data (figures, tables)
261- Reference established methods
262- Show you have necessary resources
263- Demonstrate expertise
264- Indicate prior success
266**Don't**:
267- Relegate all preliminary data to Research Strategy
268- Make it seem like you're starting from scratch
269- Propose overly ambitious aims without support

Show Feasibility

Throughout the aims page:

  • Mention preliminary data (figures, tables)
  • Reference established methods
  • Show you have necessary resources
  • Demonstrate expertise
  • Indicate prior success

Don't:

  • Relegate all preliminary data to Research Strategy
  • Make it seem like you're starting from scratch
  • Propose overly ambitious aims without support
Raw lines 257 to 270
271## Common Mistakes

Common Mistakes

Raw lines 271 to 272
273### Mistake 1: Too Much Background
275❌ Half page of background before getting to aims
277✅ Focused background that motivates your specific approach
279The aims page is NOT a mini review article. Provide only enough background to establish importance and gaps.

Mistake 1: Too Much Background

❌ Half page of background before getting to aims

✅ Focused background that motivates your specific approach

The aims page is NOT a mini review article. Provide only enough background to establish importance and gaps.

Raw lines 273 to 280
281### Mistake 2: Vague Objectives
283❌ "We will study the mechanisms of disease X"
284❌ "We will investigate the role of protein Y"
286✅ "We will identify the phosphorylation sites on protein Y that regulate its interaction with Z using mass spectrometry and mutagenesis"

Mistake 2: Vague Objectives

❌ "We will study the mechanisms of disease X" ❌ "We will investigate the role of protein Y"

✅ "We will identify the phosphorylation sites on protein Y that regulate its interaction with Z using mass spectrometry and mutagenesis"

Raw lines 281 to 287
288### Mistake 3: Overly Ambitious Scope
290❌ Four aims, each of which could be a separate R01
291❌ Proposing to solve multiple major questions in the field
292❌ "Boil the ocean" approach
294✅ Focused aims that are achievable within the permitted project period

Mistake 3: Overly Ambitious Scope

❌ Four aims, each of which could be a separate R01 ❌ Proposing to solve multiple major questions in the field ❌ "Boil the ocean" approach

✅ Focused aims that are achievable within the permitted project period

Raw lines 288 to 295
296### Mistake 4: Dependent Aims
298❌ Aim 2 and Aim 3 both require Aim 1 to succeed
300✅ Aims are synergistic but independent (failure of one doesn't doom the others)

Mistake 4: Dependent Aims

❌ Aim 2 and Aim 3 both require Aim 1 to succeed

✅ Aims are synergistic but independent (failure of one doesn't doom the others)

Raw lines 296 to 301
302### Mistake 5: No Preliminary Data Mentioned
304❌ Seems like a fishing expedition
305❌ Reviewers wonder if it's feasible
307✅ Brief mentions of preliminary data throughout (refer to figures)

Mistake 5: No Preliminary Data Mentioned

❌ Seems like a fishing expedition ❌ Reviewers wonder if it's feasible

✅ Brief mentions of preliminary data throughout (refer to figures)

Raw lines 302 to 308
309### Mistake 6: Weak Impact Statement
311❌ "This will advance our understanding of X"
312❌ "Results will be published and presented"
314✅ "This will identify new therapeutic targets for disease X, affecting 500,000 patients annually, and provide the foundation for investigator-initiated clinical trials"

Mistake 6: Weak Impact Statement

❌ "This will advance our understanding of X" ❌ "Results will be published and presented"

✅ "This will identify new therapeutic targets for disease X, affecting 500,000 patients annually, and provide the foundation for investigator-initiated clinical trials"

Raw lines 309 to 315
316### Mistake 7: Jargon-Heavy First Paragraph
318❌ Opening sentence full of abbreviations and specialized terminology
319❌ Assumes all reviewers are experts in your subfield
321✅ Opening that's comprehensible to broad scientific audience

Mistake 7: Jargon-Heavy First Paragraph

❌ Opening sentence full of abbreviations and specialized terminology ❌ Assumes all reviewers are experts in your subfield

✅ Opening that's comprehensible to broad scientific audience

Raw lines 316 to 322
323### Mistake 8: No Clear Hypothesis
325❌ Just listing aims without unifying framework
326❌ Aims without a clear question or contribution
328✅ A unifying hypothesis, research question or development objective suited to the work

Mistake 8: No Clear Hypothesis

❌ Just listing aims without unifying framework ❌ Aims without a clear question or contribution

✅ A unifying hypothesis, research question or development objective suited to the work

Raw lines 323 to 329
330### Mistake 9: Forgetting Page Limits
332❌ Exceeding the applicable page maximum (risks validation failure or return without review)
333❌ Tiny fonts to cram in more content (violations)
335✅ Within the page maximum with compliant formatting

Mistake 9: Forgetting Page Limits

❌ Exceeding the applicable page maximum (risks validation failure or return without review) ❌ Tiny fonts to cram in more content (violations)

✅ Within the page maximum with compliant formatting

Raw lines 330 to 336
337### Mistake 10: Not Telling a Story
339❌ Disconnected aims that feel like 3 separate projects
340❌ No logical flow or coherence
342✅ Unified narrative with aims building on each other

Mistake 10: Not Telling a Story

❌ Disconnected aims that feel like 3 separate projects ❌ No logical flow or coherence

✅ Unified narrative with aims building on each other

Raw lines 337 to 343
344## Advanced Tips
346### Use Visual Elements
348**Figures on Specific Aims Page**:
349- NIH allows figures on aims page
350- Can be very effective to show key preliminary data
351- Must be legible at 100%; NIH permits smaller graphic text under its attachment rules
352- Don't let figure crowd out text
353- Typical: 1 small figure or panel showing most critical data
355**Tables**:
356- Can summarize preliminary data compactly
357- Show patient characteristics, gene lists, etc.
358- Must be readable

Use Visual Elements

Figures on Specific Aims Page:

  • NIH allows figures on aims page
  • Can be very effective to show key preliminary data
  • Must be legible at 100%; NIH permits smaller graphic text under its attachment rules
  • Don't let figure crowd out text
  • Typical: 1 small figure or panel showing most critical data

Tables:

  • Can summarize preliminary data compactly
  • Show patient characteristics, gene lists, etc.
  • Must be readable
Raw lines 346 to 359
360### Strategic Use of Bold/Italics
362**Appropriate**:
363- Bold aim statements to make them stand out
364- Italicize gene names (standard convention)
365- Underline key points (sparingly)
367**Avoid**:
368- Excessive formatting that looks cluttered
369- All caps (looks like shouting)
370- Colors (may not print/display correctly)

Strategic Use of Bold/Italics

Appropriate:

  • Bold aim statements to make them stand out
  • Italicize gene names (standard convention)
  • Underline key points (sparingly)

Avoid:

  • Excessive formatting that looks cluttered
  • All caps (looks like shouting)
  • Colors (may not print/display correctly)
Raw lines 360 to 371
372### The "Skim Test"
374**Your aims page should pass the skim test**:
375- Someone reading just aim statements should understand the project
376- Bold aim statements that can be read independently
377- Each paragraph has clear topic sentence
378- Logical flow is apparent even when skimming
380**Exercise**: Ask colleague to read only bold/underlined text—can they understand the project?

The "Skim Test"

Your aims page should pass the skim test:

  • Someone reading just aim statements should understand the project
  • Bold aim statements that can be read independently
  • Each paragraph has clear topic sentence
  • Logical flow is apparent even when skimming

Exercise: Ask colleague to read only bold/underlined text—can they understand the project?

Raw lines 372 to 381
382### Tailoring to Career Stage
384**Early Stage Investigators**:
385- Show you've thought through challenges
386- Demonstrate strong mentorship and institutional support
387- Emphasize innovation while ensuring feasibility
388- Don't over-promise
390**Established Investigators**:
391- Show how this extends your research program
392- Emphasize track record implicitly
393- Can propose more ambitious aims if supported by extensive preliminary data
394- Show how this opens new directions

Tailoring to Career Stage

Early Stage Investigators:

  • Show you've thought through challenges
  • Demonstrate strong mentorship and institutional support
  • Emphasize innovation while ensuring feasibility
  • Don't over-promise

Established Investigators:

  • Show how this extends your research program
  • Emphasize track record implicitly
  • Can propose more ambitious aims if supported by extensive preliminary data
  • Show how this opens new directions
Raw lines 382 to 395
396## Examples of Strong Opening Paragraphs

Examples of Strong Opening Paragraphs

Raw lines 396 to 397
398### Example 1: Cancer Biology
400"[Cited evidence] identifies treatment resistance as an important problem in [defined breast-cancer population]. The role of [specific mechanism] remains unresolved. The proposed work tests [applicant hypothesis] to determine [knowledge gained], without assuming that a preclinical result establishes clinical benefit."

Example 1: Cancer Biology

"[Cited evidence] identifies treatment resistance as an important problem in [defined breast-cancer population]. The role of [specific mechanism] remains unresolved. The proposed work tests [applicant hypothesis] to determine [knowledge gained], without assuming that a preclinical result establishes clinical benefit."

Raw lines 398 to 401
402### Example 2: Neuroscience
404"Alzheimer's disease creates [current, cited burden]. Despite available treatments, [specific, evidence-supported limitation] remains. We will investigate [defined mechanistic question] using [applicant design]. Findings could inform [bounded future step]." Do not claim that no disease-modifying therapies exist.

Example 2: Neuroscience

"Alzheimer's disease creates [current, cited burden]. Despite available treatments, [specific, evidence-supported limitation] remains. We will investigate [defined mechanistic question] using [applicant design]. Findings could inform [bounded future step]." Do not claim that no disease-modifying therapies exist.

Raw lines 402 to 405
406### Example 3: Infectious Disease
408"Antimicrobial resistance in [defined population/pathogen] causes [current, cited burden]. Existing treatment options leave [documented gap]. We will test [investigator approach] against [specified baseline], measuring efficacy and possible resistance-related tradeoffs rather than assuming either."

Example 3: Infectious Disease

"Antimicrobial resistance in [defined population/pathogen] causes [current, cited burden]. Existing treatment options leave [documented gap]. We will test [investigator approach] against [specified baseline], measuring efficacy and possible resistance-related tradeoffs rather than assuming either."

Raw lines 406 to 409
410## Revision Checklist
412Before finalizing, ensure your aims page:
414**Content**:
415- [ ] Opens with compelling statement of importance
416- [ ] Clearly defines the gap or problem
417- [ ] States specific, measurable objective
418- [ ] Presents testable hypothesis (or focused research questions)
419- [ ] Mentions preliminary data supporting feasibility
420- [ ] Aim count and scope are justified by the science and resources
421- [ ] Each aim is testable and achievable
422- [ ] Aims are independent but synergistic
423- [ ] Expected outcomes are clearly stated
424- [ ] Closes with impact and significance
426**Clarity**:
427- [ ] First paragraph is accessible to non-specialists
428- [ ] Technical terms are defined
429- [ ] Abbreviations are spelled out at first use
430- [ ] Logical flow is clear
431- [ ] Aim statements can stand alone
432- [ ] Language is confident and active
434**Format**:
435- [ ] Within the applicable one-page maximum
436- [ ] At least 0.5-inch margins
437- [ ] At least 11-point body text; legible graphic text under the applicable exception
438- [ ] Readable line spacing
439- [ ] Compliant with NIH formatting requirements
440- [ ] Figures (if included) are legible
442**Impact**:
443- [ ] Passes the "skim test"
444- [ ] Would make you excited if you were a reviewer
445- [ ] Clearly articulates significance
446- [ ] Shows feasibility without over-selling
447- [ ] Connects to health or scientific impact

Revision Checklist

Before finalizing, ensure your aims page:

Content:

  • [ ] Opens with compelling statement of importance
  • [ ] Clearly defines the gap or problem
  • [ ] States specific, measurable objective
  • [ ] Presents testable hypothesis (or focused research questions)
  • [ ] Mentions preliminary data supporting feasibility
  • [ ] Aim count and scope are justified by the science and resources
  • [ ] Each aim is testable and achievable
  • [ ] Aims are independent but synergistic
  • [ ] Expected outcomes are clearly stated
  • [ ] Closes with impact and significance

Clarity:

  • [ ] First paragraph is accessible to non-specialists
  • [ ] Technical terms are defined
  • [ ] Abbreviations are spelled out at first use
  • [ ] Logical flow is clear
  • [ ] Aim statements can stand alone
  • [ ] Language is confident and active

Format:

  • [ ] Within the applicable one-page maximum
  • [ ] At least 0.5-inch margins
  • [ ] At least 11-point body text; legible graphic text under the applicable exception
  • [ ] Readable line spacing
  • [ ] Compliant with NIH formatting requirements
  • [ ] Figures (if included) are legible

Impact:

  • [ ] Passes the "skim test"
  • [ ] Would make you excited if you were a reviewer
  • [ ] Clearly articulates significance
  • [ ] Shows feasibility without over-selling
  • [ ] Connects to health or scientific impact
Raw lines 410 to 448
449## Final Thoughts
451Revise the Specific Aims page together with the full research strategy:
453- Revise until the question, approach and scope are clear
454- Get feedback from colleagues and mentors
455- Test it on people outside your field
456- Read it aloud to check flow
457- Let it sit, then revise with fresh eyes
458- Study funded examples in your field
460Communicate importance, innovation and feasibility without assuming a particular reviewer workload or promising that writing quality guarantees funding.
462---
464**Key Takeaway**: The perfect Specific Aims page tells a compelling story within the page limit—establishing a significant problem, presenting an innovative and feasible solution, showing preliminary evidence of success, and articulating transformative impact. Every sentence must earn its place.

Final Thoughts

Revise the Specific Aims page together with the full research strategy:

  • Revise until the question, approach and scope are clear
  • Get feedback from colleagues and mentors
  • Test it on people outside your field
  • Read it aloud to check flow
  • Let it sit, then revise with fresh eyes
  • Study funded examples in your field

Communicate importance, innovation and feasibility without assuming a particular reviewer workload or promising that writing quality guarantees funding.


Key Takeaway: The perfect Specific Aims page tells a compelling story within the page limit—establishing a significant problem, presenting an innovative and feasible solution, showing preliminary evidence of success, and articulating transformative impact. Every sentence must earn its place.

Raw lines 449 to 464